Navigation Links
Global Nuclear Medicine Market Report 2013-2017
Date:12/27/2013

DUBLIN, December 27, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/tn88ln/nuclear_medicine) has announced the addition of the "Global Nuclear Medicine Market Report 2013-2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lion's share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope. Furthermore, the PET market will witness a double digit growth during the forecast period.

The therapeutic segment contributes only 10% to the global radiopharmaceuticals market and I-131 has been considered as the gold standard for various oncology treatments in a combined therapy. Global nuclear medicines market is majorly driven by the increasing adoption of PET and SPECT scanners, and rising awareness for radiopharmaceuticals, whereas short half life of isotopes and stringent regulations are the factors that are hindering the growth of radiopharmaceuticals worldwide.

Besides highly preferred isotopes such as Tc-99m and F-18, significant growth is witnessed for Tl-201 and Rb-82 in diagnostic market and Y-90 and Lu-177 in beta therapy radioisotopes market. Exhaustive pipeline analysis reveals that coronary heart disease, Alzheimer's disease, breast cancer, and bone metastasis will drive the diagnostic radiopharmaceuticals market, whereas lymphoma, prostate cancer, bone metastasis, and hepatocellular carcinoma will boost the future of therapeutic radiopharmaceuticals. Besides new applications, the potential molecules that are expected to drive the market include Alpharadin (Ra-223), Ga-68, F-18 florbetapir, and F-18 choline. Though Ra-223 application is still under clinical trial, the market is highly optimistic regarding its clinical efficiency in prostate cancer, and bone metastasis.

Key Topics Covered:

1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology

2 Executive Summary

3 Market Overview
3.1 Definition Of Radiopharmaceuticals
3.2 Evolution
3.3 Market Segmentation
3.4 Market Dynamics
3.5 Winning Imperatives
3.6 Burning Issues
3.7 Market Share Analysis
3.8 Value Chain Analysis
3.9 Pipeline Analysis
3.10 Demand & Supply Analysis
3.11 Strategic Benchmarking
3.12 Regulatory Affairs

4 Global Radiopharmaceuticals Market, By Value
4.1 Introduction
4.2 Diagnostic Market
4.3 Therapeutic Market

5 Global Radiopharmaceuticals Market, By Procedural Volume
5.1 Introduction
5.2 Diagnostic Market
5.3 Therapeutic Market

6 Radiopharmaceuticals Market, By Application/Indication
6.1 Introduction
6.2 Diagnostic Market
6.3 Therapeutic Application

7 Enriched Stable Isotopes Market
7.1 Introduction
7.2 Market Overview
7.3 Market Dynamics
7.4 Enriched Stables Market, By Isotopes
7.5 Enriched Stables Market, By Applications

8 Geographic Analysis
8.1 Introduction
8.2 Diagnostic Market
8.3 Therapy Market
8.4 Enriched Stable Isotopes Market

9 Competitive Landscape
9.1 Introduction
9.2 Mergers & Acquisitions
9.3 Agreements, Partnerships, Collaborations & Joint Ventures
9.4 Products Launch
9.5 Expansions
9.6 Other Developments
9.7 Approvals

10 Company Profiles


Companies Mentioned:

  • Bracco Imaging SPA
  • Cambridge Isotope Laboratories, Inc
  • Cardinal Health, Inc
  • Covidien, Plc
  • Eczacibasi-Monrol
  • Fujifilm Holdings Corporation
  • Ge Healthcare (Subsidiary Of General Electric Company)
  • Iba Group
  • Isotec, Inc (Sigma-Aldrich)
  • Lantheus Medical Imaging, Inc
  • Nordion, Inc
  • Ntp Radioisotopes (PTY), Ltd
  • Petnet Solutions, Inc (A Subsidiary Of Siemens Medical Solutions Usa, Inc)
  • Rotem Industries, Ltd, Inc
  • Taiyo Nippon Sanso Corporation
  • Urenco Limited

For more information visit http://www.researchandmarkets.com/research/tn88ln/nuclear_medicine


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017 Under the impetus ... packaging market size increased year by year at ... to 2021, the market size will maintain the ... to outnumber RMB140 billion in 2021, thanks to ... development of biological agents and supporting policies. ...
(Date:3/22/2017)... March 22, 2017 New Jersey,s ... of patient harm and saved $641 million in healthcare ... in a national quality improvement program. ... for Patients-New Jersey, part of a national initiative from ... selected the New Jersey Hospital Association and its affiliate, ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets ... Point Inhibitors Market & Clinical Pipeline Insight 2022" drug ... ... & Clinical Pipeline Insight 2022 report gives comprehensive insight on ... of immune check point inhibitors as main streamline drugs in ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... ... An intensive search of the medical literature has revealed no research yet on ... He says investigating this possibility, is important because Miami-Dade in 2016 led the U.S. ... , His findings appear on Analizir.com. . Dr. Norins, who trained ...
(Date:3/22/2017)... , ... March 22, 2017 , ... Last year, 43 ... a US Department of Agriculture report. While excess dairy can be caused by ... role. Lactose sensitivity is the inability to properly digest lactose, a sugar found in ...
(Date:3/22/2017)... ... 22, 2017 , ... The Vanderbeck Agency, a Long Island firm providing insurance, ... embarking on a combined charity effort with the Great Neck Breast Cancer Coalition to ... the Great Neck Breast Cancer Coalition has worked to support breast cancer patients in ...
(Date:3/22/2017)... ... 2017 , ... The Zabbia Insurance Agency, a Long Island ... owners in the greater Nassau County area, is embarking on a cancer awareness ... minutes, someone in America is diagnosed with blood cancer. Every 9 minutes, someone ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Senior Citizens League (TSCL) is ... default on the federal debt — including the debt held by the Social Security ... said TSCL in a letter to House and Senate budget leaders. “In prior ...
Breaking Medicine News(10 mins):